HO
Schedule 13G filing
Hirschman Orin disclosed a 5.9% stake in KYTX
Hirschman Orin reported owning 5.9% of Kyverna Therapeutics, Inc. (KYTX) (3,650,000 shares) in a Schedule 13G filed Oct 19, 2026.
A 13G is a passive stake: the holder does not plan to push for changes.
- Disclosed
- Oct 19, 2026
- Source
- Schedule 13G
From a public Schedule 13G, linked above. Not investment advice, and not a recommendation to buy or sell.